Therapeutic Asset Ratings
396 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
ly4170156
Colorectal Neoplasm
Eli Lilly and Company
P1
C
(39)
ly4170156
Ovarian Neoplasm
Eli Lilly and Company
P1
C
(39)
ly4175408
Metastatic Neoplasm
Eli Lilly and Company
P1
C
(39)
ly4256984
Amyotrophic Lateral Sclerosis
Eli Lilly and Company
P1
C
(39)
ly4257496
Colorectal Neoplasm
Eli Lilly and Company
P1
C
(39)
ly4257496
Metastatic Neoplasm
Eli Lilly and Company
P1
C
(39)
ly4337713
Cholangiocarcinoma
Eli Lilly and Company
P1
C
(39)
ly4337713
Colorectal Neoplasm
Eli Lilly and Company
P1
C
(39)
ly4337713
Ovarian Neoplasm
Eli Lilly and Company
P1
C
(39)
Olomorasib
Cancer
Eli Lilly and Company
P1
C
(39)
[Ac-225]-Psma-62
Metastatic Prostate Carcinoma
Eli Lilly and Company
P1
C
(37)
Calcium folinate pentahydrate
Metastatic Solid Tumor
Eli Lilly and Company
P1
C
(37)
Eloxatin
Metastatic Solid Tumor
Eli Lilly and Company
P1
C
(37)
Imlunestrant
Endometrial Carcinoma
Eli Lilly and Company
P1
C
(37)
Itraconazole
Triple-Negative Breast Carcinoma
Eli Lilly and Company
P1
C
(37)
Loperamide
Breast Neoplasm
Eli Lilly and Company
P1
C
(37)
Loxo-260
Non-Small Cell Lung Carcinoma
Eli Lilly and Company
P1
C
(37)
ly3023414
Breast Neoplasm
Eli Lilly and Company
P1
C
(37)
ly3439539
Alzheimer Disease
Eli Lilly and Company
P1
C
(37)
ly3537031
Obesity Disorder
Eli Lilly and Company
P1
C
(37)
ly3954068
Alzheimer Disease
Eli Lilly and Company
P1
C
(37)
ly3962673
Pancreatic Ductal Adenocarcinoma
Eli Lilly and Company
P1
C
(37)
ly4006895
Alzheimer Disease
Eli Lilly and Company
P1
C
(37)
ly4006896
Parkinson Disease
Eli Lilly and Company
P1
C
(37)
ly4050784
Metastatic Solid Tumor
Eli Lilly and Company
P1
C
(37)
Showing 326 to 350 of 396 assets
Previous
Page 14 of 16
Next
